HIV-1 envelope protein gp120 triggers a Th2 response in mice that shifts to Th1 in the presence of human growth hormone

By Mellado M.   Llorente M.   Rodriguez-Frade J.M.   Lucas P.   Martinez-A C.   del Real G.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1111-1115

Elsevier

Access to resources Recommend Favorite

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

By Barnett S.W.   Rajasekar S.   Legg H.   Doe B.   Fuller D.H.   Haynes J.R.   Walker C.M.   Steimer K.S.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 869-873

Elsevier

Access to resources Recommend Favorite

Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120

By Fouts T.R.   Tuskan R.G.   Chada S.   Hone D.M.   Lewis G.K.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1697-1705

Elsevier

Access to resources Recommend Favorite

Molecular basis of the inefficacy and possible harmful effects of AIDS vaccine candidates based on HIV-1 envelope glycoprotein gp120

By Veljkovic V.   Johnson E.   Metlas R.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 473-474

Elsevier

Access to resources Recommend Favorite

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1)

By Montero M.   Menendez A.   del Carmen Dominguez M.   Navea L.   Vilarubia O.L.   Quintana D.   Izquierdo M.   Jimenez V.   Reyes O.   Lobaina L.   Noa E.   Duarte C.A.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1200-1208

Elsevier

Access to resources Recommend Favorite